News
Comphya Receives FDA IDE Approval to Initiate U.S. Clinical Trial for CaverSTIM
06 January 2025PRESS RELEASE Lausanne, Switzerland – January 06, 2025 – Comphya SA, a pioneering medical technology company and the developer of CaverSTIM, the first implantable neuromodulator...
Read more
Successful Closure of Series A First Tranche for CHF 4.35M
23 December 2024PRESS RELEASE Lausanne, Switzerland – December 23, 2024 – Comphya SA, a pioneering medical technology company and the developer of CaverSTIM, the first implantable neuromodulator...
Read more
Comphya SA Completes First-Phase Implantation Group of Pilot Post-Prostatectomy Trial in Melbourne, Australia.
17 December 2024PRESS RELEASE Lausanne, Switzerland, December 17, 2024 – Comphya SA, a pioneering medical technology company and the developer of CaverSTIM, the first implantable neuromodulator designed...
Read more
Comphya SA Receives Approval to Launch Clinical Study for CaverSTIM in Prostatectomy Patients in Brazil
23 August 2024PRESS RELEASE Lausanne, Switzerland, August 23rd, 2024 – Comphya SA, a pioneering medical technology company and the developer of CaverSTIM, the first implantable neuromodulator designed...
Read more
Comphya SA advances clinical development program with successful inaugural surgery for erectile dysfunction in Spinal Cord Injury Individuals
02 November 2023PRESS RELEASE Lausanne, Switzerland, November 02nd, 2023 – Comphya SA, a leading innovator in medical technology for erectile dysfunction solutions, announces a significant advance in...
Read more
World first medical device implantation to restore erectile function
21 August 2023PRESS RELEASE A world first implantation of a high-tech, battery-powered device to restore erectile function, has taken place at the Royal Melbourne Hospital (RMH) leading...
Read more
Comphya SA Launches Groundbreaking Clinical Study for Erectile Dysfunction Treatment in Spinal Cord Injury Patients in Brazil
10 July 2023PRESS RELEASE Lausanne, Switzerland, July 10th, 2023 – Comphya SA, a pioneering medical technology company, is excited to announce the initiation of a groundbreaking clinical...
Read more
Comphya SA Commences Recruitment for Pilot Clinical Study in Prostatectomy Patients
05 June 2023PRESS RELEASE Lausanne, Switzerland, June 5th, 2023 - Comphya SA and the Australian Prostate Centre (APC) to announce the initiation of a pioneering pilot clinical...
Read more
Comphya receives approval for first pilot clinical trial in Australia
02 March 2023PRESS RELEASE Lausanne, Switzerland, March 2nd, 2023. Comphya SA, developer of the first neuromodulator to treat erectile dysfunction (ED), announced today that Australian regulatory authorities...
Read more
Comphya successfully raises additional funds for pilot clinical trials
31 January 2023PRESS RELEASE Lausanne, Switzerland, January 31st, 2023. Comphya SA, developer of the first neuromodulator to treat erectile dysfunction (ED), today announced the fundraising of CHF...
Read more